Dergiler / Diagnostic and Interventional Radiology / 2019 / Cilt: 25 - Sayı: 4

The interaction between irreversible electroporation therapy (IRE) and embolization material using a validated vegetal model: an experimental study

Sayfa
304–309
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Furthermore, there was no physical degradation of the embolic agents or surgical clips, and this may have importance when considering IRE ablation of previously embolized lesions in vivo.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:PURPOSE Irreversible electroporation (IRE) is a nonthermal tumor ablation technique that induces cell apoptosis while preserving extracellular architecture.
📊
Temel Bulgular & Veri:Tubers were imaged with magnetic resonance imaging (MRI) 18–24 hours after ablation and the ablated field dimensions were measured.
💡
Sonuç & Katkı:Furthermore, there was no physical degradation of the embolic agents or surgical clips, and this may have importance when considering IRE ablation of previously embolized lesions in vivo.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

PURPOSE Irreversible electroporation (IRE) is a nonthermal tumor ablation technique that induces cell apoptosis while preserving extracellular architecture. Surgical clips and embolic agents may lie adjacent to, or within, the target lesion. It is unknown to date if IRE causes degradation to the embolic agents or surgical clips that may have adverse effects to patients. We aimed to examine the effects of the IRE on the morphology of various embolic agents and the effects of these agents to the ablation field using a previously validated vegetal model. METHODS Metallic surgical clips and various metallic and nonmetallic embolic agents were inserted within the center of the tuber ablation field. Additionally, clips were inserted on the edge and outside the ablation field. One tuber was ablated as a control. Ablation settings were based on previous published experiments. Tubers were imaged with magnetic resonance imaging (MRI) 18–24 hours after ablation and the ablated field dimensions were measured. Nonmetallic embolic agents were examined microscopically by the pathologist. RESULTS Nonmetallic agents did not affect the ablation pattern. Metallic implants, however, caused arcing of the ablation margins. There was no macroscopic or microscopic degradation to the agents after IRE. CONCLUSION The ablation zone arced in the presence of surgical clips at the edge or outside the ablation margins; therefore, nearby critical structures may be susceptible to the effects of IRE. Furthermore, there was no physical degradation of the embolic agents or surgical clips, and this may have importance when considering IRE ablation of previously embolized lesions in vivo.

🔖

Bu Makaleye Atıf Yap

CHAN, P., MCLEAN, C., GOH, G. S., CHAN, S. (2019). The interaction between irreversible electroporation therapy (IRE) and embolization material using a validated vegetal model: an experimental study. Diagnostic and Interventional Radiology, Cilt: 25 - Sayı: 4, 304–309. https://ajindex.com/articles/157953

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Teratani T, Yoshida H, Shiina S, et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 2006; 43:1101–1108. [CrossRef] 2. Thomson KR, Cheung W, Ellis SJ, et al. Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 2011; 22:611– 621. [CrossRef] 3. Sugimoto K, Moriyasu F, Kobayashi Y, et al. Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan. Jpn J Radiol 2015; 33:424–432. [CrossRef] 4. Kingham TP, Karkar AM, D'Angelica MI, et al. Ablation of perivascular hepatic malignant tumors with irreversible electroporation. J Am Coll Surg 2012; 215:379–387. [CrossRef] 5. Mansson C, Nilsson A, Karlson BM. Severe complications with irreversible electroporation of the pancreas in the presence of a metallic stent: a warning of a procedure that never should be performed. Acta Radiol Short Rep 2014; 3:2047981614556409. [CrossRef] 6. Ivorra A, Mir LM, Rubinsky B. Electric field redistribution during tissue electroporation: its potential impact on treatment planning. 2010. Available from: http://berg.upf.edu/system/ files/biblio/Accepted.pdf. 7. Ivorra A, Mir LM, Rubinsky B. Electric field redistribution due to conductivity changes during tissue electroporation: experiments with a simple vegetal model. Berlin: Springer; 2009; 59–62. 8. Neal RE, 2nd, Smith RL, Kavnoudias H, et al. The effects of metallic implants on electroporation therapies: feasibility of irreversible electroporation for brachytherapy salvage. Cardiovasc Intervent Radiol 2013; 36:1638–1645. [CrossRef] 9. Wagstaff PG, Buijs M, van den Bos W, et al. Irreversible electroporation: state of the art. Onco Targets Ther 2016; 9:2437–2446. [CrossRef] 10. Thomson KR, Kavnoudias H, Neal RE, 2nd. Introduction to irreversible electroporation--principles and techniques. Tech Vasc Interv Radiol 2015; 18:128–134. [CrossRef] 11. Li S, Chen F, Shen L, Zeng Q, Wu P. Percutaneous irreversible electroporation for breast tissue and breast cancer: safety, feasibility, skin effects and radiologic-pathologic correlation in an animal study. J Transl Med 2016; 14:238. [CrossRef] 12. Lee EW, Thai S, Kee ST. Irreversible electroporation: a novel image-guided cancer therapy. Gut Liver 2010; 4 Suppl 1:S99–S104. [CrossRef] 13. Smeets AJ, Nijenhuis RJ, van Rooij WJ, et al. Embolization of uterine leiomyomas with polyzene F-coated hydrogel microspheres: initial exp